Ping Zhou

Interferon- γ and infectious diseases: Lessons and prospects

Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours

Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images

A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy